General

Showing 1585–1600 of 2301 results

Article: P14 FROM THE ANTIPLATELET DRUG TICAGRELOR TO NEW ANTIBIOTICS
€3.03 Add to cart
Article: P14 PRELIMINARY EVALUATION OF ADAMTS-13 ANTIBODY TESTING
€3.03 Add to cart
Article: P14 The impact of the updated IMWG diagnostic criteria in a real-life SMM cohort: a single center experience
€3.03 Add to cart
Article: P15 Chronic myeloid leukemia initially presenting with acute haemopericardium and cardiac tamponade: case presentation and identification of a possible pitfall
€3.03 Add to cart
Article: P15 OPTIMISATION OF THE CALIBRATION CURVE FOR THE ACCURATE MEASUREMENT OF LOW FVIII LEVELS WITH ONE-STAGE ASSAYS
€3.03 Add to cart
Article: P15 REAL-WORLD EXPERIENCE OF SWITCHING FROM SHL-RFIX TO EHL-RFIXFC IN MODERATE AND SEVERE HAEMOPHILIA B PATIENTS: A RETROSPECTIVE ANALYSIS FROM TWO BELGIAN CENTERS
€3.03 Add to cart
Article: P15 Treatment patterns of Waldenström’s macroglobulinemia in Belgium
€3.03 Add to cart
Article: P16 HEAD TO HEAD COMPARISON OF COAGULATION, PLATELET ACTIVATION AND NETOSIS IN SEPTIC SHOCK AND CRITICAL COVID-19 PATIENTS ADMITTED IN THE ICU
€3.03 Add to cart
Article: P16 HOW TO DEAL WITH SAMPLES WITH ERRORS ON APTT, PT AND FIBRINOGEN DUE TO OPTICAL CLOT DETECTION?
€3.03 Add to cart
Article: P16 Preleukemic phase of chronic myeloid leukemia presenting with an isolated peripheral basocytosis
€3.03 Add to cart
Article: P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry
€3.03 Add to cart
Article: P17 ANTI-CYSTEINE/SPACER AUTOANTIBODIES PLAY A MAJOR ROLE IN INDUCING AN OPEN ADAMTS13 CONFORMATION IN IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
€3.03 Add to cart
Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
€3.03 Add to cart
Article: P17 Diagnostic strength of bone marrow aspirate versus biopsy in (smoldering) multiple myeloma patients
€3.03 Add to cart
Article: P17 ESTABLISHMENT OF A THROMBIN GENERATION THRESHOLD IN SEVERE HAEMOPHILIAC PATIENTS UNDER PROPHYLAXIS TO FURTHER DETERMINE AN ADDED VALUE OF THIS TEST IN THE PERSONALIZED TREATMENT: A PILOT STUDY
€3.03 Add to cart
Article: P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life
€3.03 Add to cart

Article: P14 FROM THE ANTIPLATELET DRUG TICAGRELOR TO NEW ANTIBIOTICS

Article: P14 PRELIMINARY EVALUATION OF ADAMTS-13 ANTIBODY TESTING

Article: P14 The impact of the updated IMWG diagnostic criteria in a real-life SMM cohort: a single center experience

Article: P15 Chronic myeloid leukemia initially presenting with acute haemopericardium and cardiac tamponade: case presentation and identification of a possible pitfall

Article: P15 OPTIMISATION OF THE CALIBRATION CURVE FOR THE ACCURATE MEASUREMENT OF LOW FVIII LEVELS WITH ONE-STAGE ASSAYS

Article: P15 REAL-WORLD EXPERIENCE OF SWITCHING FROM SHL-RFIX TO EHL-RFIXFC IN MODERATE AND SEVERE HAEMOPHILIA B PATIENTS: A RETROSPECTIVE ANALYSIS FROM TWO BELGIAN CENTERS

Article: P15 Treatment patterns of Waldenström’s macroglobulinemia in Belgium

Article: P16 HEAD TO HEAD COMPARISON OF COAGULATION, PLATELET ACTIVATION AND NETOSIS IN SEPTIC SHOCK AND CRITICAL COVID-19 PATIENTS ADMITTED IN THE ICU

Article: P16 HOW TO DEAL WITH SAMPLES WITH ERRORS ON APTT, PT AND FIBRINOGEN DUE TO OPTICAL CLOT DETECTION?

Article: P16 Preleukemic phase of chronic myeloid leukemia presenting with an isolated peripheral basocytosis

Article: P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry

Article: P17 ANTI-CYSTEINE/SPACER AUTOANTIBODIES PLAY A MAJOR ROLE IN INDUCING AN OPEN ADAMTS13 CONFORMATION IN IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA

Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients

Article: P17 Diagnostic strength of bone marrow aspirate versus biopsy in (smoldering) multiple myeloma patients

Article: P17 ESTABLISHMENT OF A THROMBIN GENERATION THRESHOLD IN SEVERE HAEMOPHILIAC PATIENTS UNDER PROPHYLAXIS TO FURTHER DETERMINE AN ADDED VALUE OF THIS TEST IN THE PERSONALIZED TREATMENT: A PILOT STUDY

Article: P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life